MedX Signs Distribution Agreement With Technology4Medicine
MedX Health has signed an exclusive distribution agreement with Technology4Medicine, a newly formed laser company based in San Clemente, California, for the US dental, dermatology, plastic surgery and anti-aging markets.
Technology4Medicine will sell MedX Health’s newest laser product, Oralase immediately upon clearances from the FDA to dental offices. Oralase is said to be a low level laser therapy exclusively designed for dentists to alleviate pain and accelerate tissue repair following dental procedures.
The terms of the agreement include MedX giving Technology4Medicine exclusive US rights to sell Oralase and other MedX lasers that may be applicable in the dental, dermatology, plastic surgery and anti-aging markets. Increased levels of promotion are expected to cross over into these other large growth markets.
Steve Guillen, president and CEO of MedX Health, said: “As we move forward with our business plan to become the worldwide leader in light technology, MedX is committed to choosing the right partners to accelerate product distribution while continuing to develop superior products and explore new therapeutic opportunities for those products.”